Pure Global

CoviPlus RT-qPCR Kit - India CDSCO Medical Device Registration

CoviPlus RT-qPCR Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000138_86c413a6e3bbef435330c6297e1c8af1_deb44fa4273916b16b4727f6592b4240. This device is marketed under the brand name Concepta D-DIMER Control. The license holder is BIOSYSTEMS DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
CoviPlus RT-qPCR Kit
UID: MFG/IVD/2020/000138_86c413a6e3bbef435330c6297e1c8af1_deb44fa4273916b16b4727f6592b4240

Brand Name

Concepta D-DIMER Control

Device Class

Class C

Approving Authority

Central Drug Standard Control Organisation, South Zone

Product Information

The CoviPlus kit is a combination of a rapid sample preparation reagent and an RT- qPCR test for SARS-CoV2. The proprietary โ€˜CoviPrepโ€™ reagent enables rapid (Concepta D-DIMER Control) single-step sample preparation and is to be used in conjunction with the RT- qPCR kit. The single-tube multiplexed real time reverse transcription polymerase chain reaction (Concepta D-DIMER Control) is intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal (Concepta D-DIMER Control), oropharyngeal (Concepta D-DIMER Control), combined nasopharyngeal + oropharyngeal (Concepta D-DIMER Control), or nasal swab specimens.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing